News

On February 15, 2021, Celltrion Healthcare announced that the European Commission granted marketing authorization for Yuflyma™ (CT-P17), an adalimumab biosimilar, on February 11, 2021.  Yuflyma™ was approved across all thirteen intended indications covered by the reference biologic, Humira®. ...

The Fourth Circuit recently held that the U.S. District Court for the Eastern District of Virginia erred in its analysis of a defendant’s laches defense against an unfair competition claim under Section 43(a) of the Lanham Act.

The workplace safety framework in the United States is difficult to navigate at its best.

Q: Two of my employees are in conflict over one’s display of a star of David in her workspace. Hannah is Jewish. Like many employees, she displays some personal items in her workspace; she has a small Star of David sculpture....

The current flexibilities offered in the Corporate Governance and Insolvency Act 2020 for holding general meetings are due to expire on 30 March 2021 and although the Government continues to pursue the opportunity to introduce further primary legislation, this opportunity is limited, particularly

With a new presidential administration promising vigorous antitrust enforcement, and a new Democratic majority in Congress seeking to make drastic changes to U.S.

The COVID-19 pandemic has put unprecedented strain on organizations of all sizes across all industries. The uncertainty of the “new normal” is forcing employers all over the world to consider various new policies as workers return to the workplace.

Employers are facing uncertainty as to the expiration of the COVID-19 relief the U.S. Department of Labor (DOL) and Internal Revenue Service (IRS) issued in a joint guidance on May 4, 2020.

President Joe Biden signed three Executive Orders (EOs) on Jan. 27, 2021, to launch a "whole of government" approach to align federal policy with climate change, building upon three prior EOs that President Biden signed on Day One of his presidency....

Preventing retaliation is a constant uphill struggle for compliance programs. There is something in human nature that makes people want to know who made the report and ostracize him or her for it.

Pages